Bausch Health Companies Inc.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 |
|---|---|---|---|
| Revenue | $1.18B | $820.4M | $757.2M |
| Cost of Revenue | $395.6M | $204.3M | $197.2M |
| Gross Profit | $785.6M | $616.1M | $560.0M |
| Gross Margin | 66.5% | 75.1% | 74.0% |
| Operating Expenses | |||
| Research & Development | — | — | — |
| SG&A Expense | $276.5M | $167.6M | $188.9M |
| Operating Income | $-110.1M | $181.2M | $124.1M |
| Operating Margin | -9.3% | 22.1% | 16.4% |
| Interest Expense | — | — | — |
| Pretax Income | $-236.3M | $175.0M | — |
| Income Tax Expense | $-28.1M | $-1.5M | $-73.0M |
| Net Income | $366.7M | $406.6M | $199.9M |
| Net Margin | 31.0% | 49.6% | 26.4% |
| EPS (Basic) | $-1.06 | $1.11 | $1.25 |
| EPS (Diluted) | $-1.06 | $1.11 | $1.25 |
| Shares Outstanding (Basic) | 195.8M | 158.2M | 159.7M |
| Shares Outstanding (Diluted) | 195.8M | 158.5M | 159.7M |
| Dividends Per Share | $1.28 | $0.65 | $1.50 |